VEGFA and retinopathy of prematurity: A smaller FAZ area compared with a healthy control group was reported among children who had received anti‐VEGF treatment (Chen et al. 2019) and in children with a history of ROP (1–2) or of ROP 3, who received laser coagulation (Falavarjani et al. 2017; Miki et al. 2019; Nonobe et al. 2019; Takagi et al. 2019).